Objective: To evaluate complications of deep sclerectomy with collagen implant (DSCI), a recently introduced nonpenetrating glaucoma-filtering surgical technique. Patients and Methods: 30 eyes of 23 patients with open-angle glaucoma were included in this prospective, noncomparative, interventional case series. In all eyes, preoperative intraocular pressure (IOP) was lowered inadequately by topical antiglaucomatous medications. After undergoing DSCI, the patients were followed prospectively. If necessary, the procedure was combined with cataract surgery or mitomycin C application. Results: In 27 (90%) of 30 eyes, DSCI could be performed. In 3 (10%) of 30 eyes, DSCI had to be transformed intraoperatively into a trabeculectomy because of a large trabecular penetration. Microperforations without further consequences occurred in 2 (7%) of 30 eyes. The mean follow-up was 6.6 ± 3.8 months. IOP dropped from 26.0 ± 6.7 to 13.6 ± 4.7 mm Hg (p < 0.05). Medical glaucomatous treatment was reduced from 2.3 ± 3.8 to 0.3 ± 0.6 (p < 0.05). In cases without cataract, visual acuity decreased from 0.7 ± 0.3 to 0.66 ± 0.4 at the last visit (p > 0.1). Postoperative complications included Seidel (1/27, 4%), encapsulated bleb (4/27, 15%), astigmatism (1/27, 4%), iris capture (2/27, 7%), microhyphema (3/27, 11%) and peripheral anterior synechiae (4/27, 15%). Fifteen (56%) of the 27 eyes needed the following postoperative procedures: laser goniopuncture (8/27, 30%), needling of the filtering bleb (4/27, 15%), surgical revision in the operating theater (3/27, 11%). All 3 eyes where trabeculectomy was performed instead of DSCI had a favorable course. Conclusions: During the evaluation period, complications occurred in about half of the cases. None of the complications was severe or irreversible. Target pressure and a reduction in drug treatment could be achieved in all of the patients.

Keywords:
Sclerectomy, Collagen implant, Glaucoma
1.
Vesti E, Raitta C: A review of the outcome of trabeculectomy in open-angle glaucoma. Ophthalmic Surg Lasers 1997;28:128–132.
2.
Briggs MC, Jay JL: Age over 46 years does not affect the pressure lowering effect of trabeculectomy in primary open angle glaucoma. Br J Ophthalmol 1999;83:280–284.
3.
Anand N, Sahni K, Menage MJ: Modification of trabeculectomy with single-dose intraoperative 5-fluorouracil application. Acta Ophthalmol Scand 1998;76:83–89.
4.
Mermoud A, Schnyder CC, Sickenberg M, et al: Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma. J Cataract Refract Surg 1999;25:323–331.
5.
Sickenberg M, Chiou AGY, Bigar F, Mermoud A: Deep sclerectomy with collagen implant: A new non-perforating filtering study. Ophthalmology 1995;102:134.
6.
Gianoli F, Schnyder CC, Bovey E, Mermoud A: Combined surgery for cataract and glaucoma: Phacoemulsification and deep sclerectomy compared with phacoemulsification and trabeculectomy. J Cataract Refract Surg 1999;25:340–346.
7.
Sanchez E, Schnyder CC, Sickenberg M, et al: Deep sclerectomy: Results with and without collagen implant. Int Ophthalmol 1996–1997;20:157–162.
8.
Karlen ME, Sanches E, Schnyder CC, et al: Deep sclerectomy with collagen implant: Medium term results. Br J Ophthalmol 1999;83:6–11.
9.
Demailly P, Lavat P, Kretz G, et al: Non-penetrating deep sclerectomy (NPDS) with or without collagen device (CD) in primary open-angle glaucoma: Middle-term retrospective study. Int Ophthalmol 1996–1997;20:131–140.
10.
European Glaucoma Society: 1998 Terminology and Guidelines for Glaucoma. Savona, Dogma Srl, 1998, pp 81–83.
11.
Guggenbach M, Mojon DS, Bohnke M: Evaluation of phacotrabeculectomy versus trabeculectomy alone. Ophthalmologica 1999;213:367–370.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.